世界の慢性片頭痛治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Chronic Migraine Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4013 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、慢性片頭痛治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（薬物治療、代替治療）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・慢性片頭痛治療の市場動向 ・企業の競争状況、市場シェア ・慢性片頭痛治療の種類別市場規模と予測2016-2027（薬物治療、代替治療） ・慢性片頭痛治療の用途別市場規模と予測2016-2027（病院、診療所、その他） ・慢性片頭痛治療の北米市場規模2016-2027（アメリカ、カナダ） ・慢性片頭痛治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・慢性片頭痛治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・慢性片頭痛治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・慢性片頭痛治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Novartis、Pfizer、AstraZeneca、Allergan、GlaxoSmithKline、Eli Lilly、Merck、Johnson&Johnson、Zosano、Alder BioPharmaceuticals） ・結論

Migraine is a painful, episodic disease that sometimes develops into a chronic condition. It is one of the most common neurological diseases in clinical practice. Chronic migraines (CM) are a natural progression of chronic migraines, with a frequency of 15 days per month and similar characteristics to migraine attacks.

Market Analysis and Insights: Global Chronic Migraine Treatment Market
The global Chronic Migraine Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Chronic Migraine Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Chronic Migraine Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Chronic Migraine Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Chronic Migraine Treatment market.

Global Chronic Migraine Treatment Scope and Market Size
Chronic Migraine Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Chronic Migraine Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Drug Treatment
Substitution Treatment

Segment by Application
Hospitals
Clinics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Novartis
Pfizer
AstraZeneca
Allergan
GlaxoSmithKline
Eli Lilly
Merck
Johnson&Johnson
Zosano
Alder BioPharmaceuticals

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chronic Migraine Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Drug Treatment
1.2.3 Substitution Treatment
1.3 Market by Application
1.3.1 Global Chronic Migraine Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Chronic Migraine Treatment Market Perspective (2016-2027)
2.2 Chronic Migraine Treatment Growth Trends by Regions
2.2.1 Chronic Migraine Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Chronic Migraine Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Chronic Migraine Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Chronic Migraine Treatment Industry Dynamic
2.3.1 Chronic Migraine Treatment Market Trends
2.3.2 Chronic Migraine Treatment Market Drivers
2.3.3 Chronic Migraine Treatment Market Challenges
2.3.4 Chronic Migraine Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Chronic Migraine Treatment Players by Revenue
3.1.1 Global Top Chronic Migraine Treatment Players by Revenue (2016-2021)
3.1.2 Global Chronic Migraine Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Chronic Migraine Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Chronic Migraine Treatment Revenue
3.4 Global Chronic Migraine Treatment Market Concentration Ratio
3.4.1 Global Chronic Migraine Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chronic Migraine Treatment Revenue in 2020
3.5 Chronic Migraine Treatment Key Players Head office and Area Served
3.6 Key Players Chronic Migraine Treatment Product Solution and Service
3.7 Date of Enter into Chronic Migraine Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Chronic Migraine Treatment Breakdown Data by Type
4.1 Global Chronic Migraine Treatment Historic Market Size by Type (2016-2021)
4.2 Global Chronic Migraine Treatment Forecasted Market Size by Type (2022-2027)

5 Chronic Migraine Treatment Breakdown Data by Application
5.1 Global Chronic Migraine Treatment Historic Market Size by Application (2016-2021)
5.2 Global Chronic Migraine Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Chronic Migraine Treatment Market Size (2016-2027)
6.2 North America Chronic Migraine Treatment Market Size by Type
6.2.1 North America Chronic Migraine Treatment Market Size by Type (2016-2021)
6.2.2 North America Chronic Migraine Treatment Market Size by Type (2022-2027)
6.2.3 North America Chronic Migraine Treatment Market Size by Type (2016-2027)
6.3 North America Chronic Migraine Treatment Market Size by Application
6.3.1 North America Chronic Migraine Treatment Market Size by Application (2016-2021)
6.3.2 North America Chronic Migraine Treatment Market Size by Application (2022-2027)
6.3.3 North America Chronic Migraine Treatment Market Size by Application (2016-2027)
6.4 North America Chronic Migraine Treatment Market Size by Country
6.4.1 North America Chronic Migraine Treatment Market Size by Country (2016-2021)
6.4.2 North America Chronic Migraine Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Chronic Migraine Treatment Market Size (2016-2027)
7.2 Europe Chronic Migraine Treatment Market Size by Type
7.2.1 Europe Chronic Migraine Treatment Market Size by Type (2016-2021)
7.2.2 Europe Chronic Migraine Treatment Market Size by Type (2022-2027)
7.2.3 Europe Chronic Migraine Treatment Market Size by Type (2016-2027)
7.3 Europe Chronic Migraine Treatment Market Size by Application
7.3.1 Europe Chronic Migraine Treatment Market Size by Application (2016-2021)
7.3.2 Europe Chronic Migraine Treatment Market Size by Application (2022-2027)
7.3.3 Europe Chronic Migraine Treatment Market Size by Application (2016-2027)
7.4 Europe Chronic Migraine Treatment Market Size by Country
7.4.1 Europe Chronic Migraine Treatment Market Size by Country (2016-2021)
7.4.2 Europe Chronic Migraine Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Chronic Migraine Treatment Market Size (2016-2027)
8.2 Asia-Pacific Chronic Migraine Treatment Market Size by Type
8.2.1 Asia-Pacific Chronic Migraine Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Chronic Migraine Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Chronic Migraine Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Chronic Migraine Treatment Market Size by Application
8.3.1 Asia-Pacific Chronic Migraine Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Chronic Migraine Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Chronic Migraine Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Chronic Migraine Treatment Market Size by Region
8.4.1 Asia-Pacific Chronic Migraine Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Chronic Migraine Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Chronic Migraine Treatment Market Size (2016-2027)
9.2 Latin America Chronic Migraine Treatment Market Size by Type
9.2.1 Latin America Chronic Migraine Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Chronic Migraine Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Chronic Migraine Treatment Market Size by Type (2016-2027)
9.3 Latin America Chronic Migraine Treatment Market Size by Application
9.3.1 Latin America Chronic Migraine Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Chronic Migraine Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Chronic Migraine Treatment Market Size by Application (2016-2027)
9.4 Latin America Chronic Migraine Treatment Market Size by Country
9.4.1 Latin America Chronic Migraine Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Chronic Migraine Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Chronic Migraine Treatment Market Size (2016-2027)
10.2 Middle East & Africa Chronic Migraine Treatment Market Size by Type
10.2.1 Middle East & Africa Chronic Migraine Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Chronic Migraine Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Chronic Migraine Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Chronic Migraine Treatment Market Size by Application
10.3.1 Middle East & Africa Chronic Migraine Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Chronic Migraine Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Chronic Migraine Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Chronic Migraine Treatment Market Size by Country
10.4.1 Middle East & Africa Chronic Migraine Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Chronic Migraine Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Chronic Migraine Treatment Introduction
11.1.4 Novartis Revenue in Chronic Migraine Treatment Business (2016-2021)
11.1.5 Novartis Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Chronic Migraine Treatment Introduction
11.2.4 Pfizer Revenue in Chronic Migraine Treatment Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Details
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca Chronic Migraine Treatment Introduction
11.3.4 AstraZeneca Revenue in Chronic Migraine Treatment Business (2016-2021)
11.3.5 AstraZeneca Recent Development
11.4 Allergan
11.4.1 Allergan Company Details
11.4.2 Allergan Business Overview
11.4.3 Allergan Chronic Migraine Treatment Introduction
11.4.4 Allergan Revenue in Chronic Migraine Treatment Business (2016-2021)
11.4.5 Allergan Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Chronic Migraine Treatment Introduction
11.5.4 GlaxoSmithKline Revenue in Chronic Migraine Treatment Business (2016-2021)
11.5.5 GlaxoSmithKline Recent Development
11.6 Eli Lilly
11.6.1 Eli Lilly Company Details
11.6.2 Eli Lilly Business Overview
11.6.3 Eli Lilly Chronic Migraine Treatment Introduction
11.6.4 Eli Lilly Revenue in Chronic Migraine Treatment Business (2016-2021)
11.6.5 Eli Lilly Recent Development
11.7 Merck
11.7.1 Merck Company Details
11.7.2 Merck Business Overview
11.7.3 Merck Chronic Migraine Treatment Introduction
11.7.4 Merck Revenue in Chronic Migraine Treatment Business (2016-2021)
11.7.5 Merck Recent Development
11.8 Johnson&Johnson
11.8.1 Johnson&Johnson Company Details
11.8.2 Johnson&Johnson Business Overview
11.8.3 Johnson&Johnson Chronic Migraine Treatment Introduction
11.8.4 Johnson&Johnson Revenue in Chronic Migraine Treatment Business (2016-2021)
11.8.5 Johnson&Johnson Recent Development
11.9 Zosano
11.9.1 Zosano Company Details
11.9.2 Zosano Business Overview
11.9.3 Zosano Chronic Migraine Treatment Introduction
11.9.4 Zosano Revenue in Chronic Migraine Treatment Business (2016-2021)
11.9.5 Zosano Recent Development
11.10 Alder BioPharmaceuticals
11.10.1 Alder BioPharmaceuticals Company Details
11.10.2 Alder BioPharmaceuticals Business Overview
11.10.3 Alder BioPharmaceuticals Chronic Migraine Treatment Introduction
11.10.4 Alder BioPharmaceuticals Revenue in Chronic Migraine Treatment Business (2016-2021)
11.10.5 Alder BioPharmaceuticals Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Chronic Migraine Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Drug Treatment
Table 3. Key Players of Substitution Treatment
Table 4. Global Chronic Migraine Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Chronic Migraine Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Chronic Migraine Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Chronic Migraine Treatment Market Share by Regions (2016-2021)
Table 8. Global Chronic Migraine Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Chronic Migraine Treatment Market Share by Regions (2022-2027)
Table 10. Chronic Migraine Treatment Market Trends
Table 11. Chronic Migraine Treatment Market Drivers
Table 12. Chronic Migraine Treatment Market Challenges
Table 13. Chronic Migraine Treatment Market Restraints
Table 14. Global Chronic Migraine Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Chronic Migraine Treatment Market Share by Players (2016-2021)
Table 16. Global Top Chronic Migraine Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Migraine Treatment as of 2020)
Table 17. Ranking of Global Top Chronic Migraine Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Chronic Migraine Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Chronic Migraine Treatment Product Solution and Service
Table 21. Date of Enter into Chronic Migraine Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Chronic Migraine Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Chronic Migraine Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Chronic Migraine Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Chronic Migraine Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Chronic Migraine Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Chronic Migraine Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Chronic Migraine Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Chronic Migraine Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Chronic Migraine Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Chronic Migraine Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Chronic Migraine Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Chronic Migraine Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Chronic Migraine Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Chronic Migraine Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Chronic Migraine Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Chronic Migraine Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Chronic Migraine Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Chronic Migraine Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Chronic Migraine Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Chronic Migraine Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Chronic Migraine Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Chronic Migraine Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Chronic Migraine Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Chronic Migraine Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Chronic Migraine Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Chronic Migraine Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Chronic Migraine Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Chronic Migraine Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Chronic Migraine Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Chronic Migraine Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Chronic Migraine Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Chronic Migraine Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Chronic Migraine Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Chronic Migraine Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Chronic Migraine Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Chronic Migraine Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Chronic Migraine Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Chronic Migraine Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Novartis Company Details
Table 62. Novartis Business Overview
Table 63. Novartis Chronic Migraine Treatment Product
Table 64. Novartis Revenue in Chronic Migraine Treatment Business (2016-2021) & (US$ Million)
Table 65. Novartis Recent Development
Table 66. Pfizer Company Details
Table 67. Pfizer Business Overview
Table 68. Pfizer Chronic Migraine Treatment Product
Table 69. Pfizer Revenue in Chronic Migraine Treatment Business (2016-2021) & (US$ Million)
Table 70. Pfizer Recent Development
Table 71. AstraZeneca Company Details
Table 72. AstraZeneca Business Overview
Table 73. AstraZeneca Chronic Migraine Treatment Product
Table 74. AstraZeneca Revenue in Chronic Migraine Treatment Business (2016-2021) & (US$ Million)
Table 75. AstraZeneca Recent Development
Table 76. Allergan Company Details
Table 77. Allergan Business Overview
Table 78. Allergan Chronic Migraine Treatment Product
Table 79. Allergan Revenue in Chronic Migraine Treatment Business (2016-2021) & (US$ Million)
Table 80. Allergan Recent Development
Table 81. GlaxoSmithKline Company Details
Table 82. GlaxoSmithKline Business Overview
Table 83. GlaxoSmithKline Chronic Migraine Treatment Product
Table 84. GlaxoSmithKline Revenue in Chronic Migraine Treatment Business (2016-2021) & (US$ Million)
Table 85. GlaxoSmithKline Recent Development
Table 86. Eli Lilly Company Details
Table 87. Eli Lilly Business Overview
Table 88. Eli Lilly Chronic Migraine Treatment Product
Table 89. Eli Lilly Revenue in Chronic Migraine Treatment Business (2016-2021) & (US$ Million)
Table 90. Eli Lilly Recent Development
Table 91. Merck Company Details
Table 92. Merck Business Overview
Table 93. Merck Chronic Migraine Treatment Product
Table 94. Merck Revenue in Chronic Migraine Treatment Business (2016-2021) & (US$ Million)
Table 95. Merck Recent Development
Table 96. Johnson&Johnson Company Details
Table 97. Johnson&Johnson Business Overview
Table 98. Johnson&Johnson Revenue in Chronic Migraine Treatment Business (2016-2021) & (US$ Million)
Table 99. Johnson&Johnson Recent Development
Table 100. Zosano Company Details
Table 101. Zosano Business Overview
Table 102. Zosano Chronic Migraine Treatment Product
Table 103. Zosano Revenue in Chronic Migraine Treatment Business (2016-2021) & (US$ Million)
Table 104. Zosano Recent Development
Table 105. Alder BioPharmaceuticals Company Details
Table 106. Alder BioPharmaceuticals Business Overview
Table 107. Alder BioPharmaceuticals Chronic Migraine Treatment Product
Table 108. Alder BioPharmaceuticals Revenue in Chronic Migraine Treatment Business (2016-2021) & (US$ Million)
Table 109. Alder BioPharmaceuticals Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chronic Migraine Treatment Market Share by Type: 2020 VS 2027
Figure 2. Drug Treatment Features
Figure 3. Substitution Treatment Features
Figure 4. Global Chronic Migraine Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Others Case Studies
Figure 8. Chronic Migraine Treatment Report Years Considered
Figure 9. Global Chronic Migraine Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Chronic Migraine Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Chronic Migraine Treatment Market Share by Regions: 2020 VS 2027
Figure 12. Global Chronic Migraine Treatment Market Share by Regions (2022-2027)
Figure 13. Global Chronic Migraine Treatment Market Share by Players in 2020
Figure 14. Global Top Chronic Migraine Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Migraine Treatment as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Chronic Migraine Treatment Revenue in 2020
Figure 16. Global Chronic Migraine Treatment Revenue Market Share by Type (2016-2021)
Figure 17. Global Chronic Migraine Treatment Revenue Market Share by Type (2022-2027)
Figure 18. North America Chronic Migraine Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Chronic Migraine Treatment Market Share by Type (2016-2027)
Figure 20. North America Chronic Migraine Treatment Market Share by Application (2016-2027)
Figure 21. North America Chronic Migraine Treatment Market Share by Country (2016-2027)
Figure 22. United States Chronic Migraine Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Chronic Migraine Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Chronic Migraine Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Chronic Migraine Treatment Market Share by Type (2016-2027)
Figure 26. Europe Chronic Migraine Treatment Market Share by Application (2016-2027)
Figure 27. Europe Chronic Migraine Treatment Market Share by Country (2016-2027)
Figure 28. Germany Chronic Migraine Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Chronic Migraine Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Chronic Migraine Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Chronic Migraine Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Chronic Migraine Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Chronic Migraine Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Chronic Migraine Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Chronic Migraine Treatment Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Chronic Migraine Treatment Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Chronic Migraine Treatment Market Share by Region (2016-2027)
Figure 38. China Chronic Migraine Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Chronic Migraine Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Chronic Migraine Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Chronic Migraine Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Chronic Migraine Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Chronic Migraine Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Chronic Migraine Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Chronic Migraine Treatment Market Share by Type (2016-2027)
Figure 46. Latin America Chronic Migraine Treatment Market Share by Application (2016-2027)
Figure 47. Latin America Chronic Migraine Treatment Market Share by Country (2016-2027)
Figure 48. Mexico Chronic Migraine Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Chronic Migraine Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Chronic Migraine Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Chronic Migraine Treatment Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Chronic Migraine Treatment Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Chronic Migraine Treatment Market Share by Country (2016-2027)
Figure 54. Turkey Chronic Migraine Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Chronic Migraine Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Chronic Migraine Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Novartis Revenue Growth Rate in Chronic Migraine Treatment Business (2016-2021)
Figure 58. Pfizer Revenue Growth Rate in Chronic Migraine Treatment Business (2016-2021)
Figure 59. AstraZeneca Revenue Growth Rate in Chronic Migraine Treatment Business (2016-2021)
Figure 60. Allergan Revenue Growth Rate in Chronic Migraine Treatment Business (2016-2021)
Figure 61. GlaxoSmithKline Revenue Growth Rate in Chronic Migraine Treatment Business (2016-2021)
Figure 62. Eli Lilly Revenue Growth Rate in Chronic Migraine Treatment Business (2016-2021)
Figure 63. Merck Revenue Growth Rate in Chronic Migraine Treatment Business (2016-2021)
Figure 64. Johnson&Johnson Revenue Growth Rate in Chronic Migraine Treatment Business (2016-2021)
Figure 65. Zosano Revenue Growth Rate in Chronic Migraine Treatment Business (2016-2021)
Figure 66. Alder BioPharmaceuticals Revenue Growth Rate in Chronic Migraine Treatment Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

---